Finally, a large number of studies implicate KDM5D loss in the escalation of PC severity and KDM5D-deficiency found at higher frequencies in metastatic PC lesions based on the findings of many epidemiological studies [113]. This evidence concerns the gene KDM5D and pachyonychia congenita.